Language

News topic

Expected end: 2026-04

All current shortage notices related to Expected end: 2026-04, structured by product, country, active ingredient and reporting period.

7 notices

← All shortages

Belgium

Clariscan 0.5 mmol/ml inj. opl. i.v. voorgev. spuit 10 ml

Active ingredient: Tetraxetan; Gadolinium Oxide; Gadoteric Acid

View notice details →
Belgium

Myatorlip 10 mg - 40 mg filmomh. tabl. 90

Active ingredient: Ezetimibe ; Atorvastatin

View notice details →
Belgium

Ropivacaine Fresenius Kabi 2 mg/ml inj. opl. epidur. amp. 5 x 20 ml

Active ingredient: Ropivacaine Hydrochloride

View notice details →
Belgium

Perindopril Teva 5 mg filmomh. tabl. 90 (3 x 30)

Active ingredient: Perindopril

View notice details →
Belgium

Nifedipine Retard EG 30 mg tabl. verl. afgifte 98

Active ingredient: Nifedipine

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.